Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: A multi-institution analysis

HPB

Volumn 14, Issue 8, 2012, Pages 514-522

  Fisher, Sarah B ^a   Patel, Sameer H ^a   Kooby, David A ^a   Weber, Sharon ^b   Bloomston, Mark ^c   Cho, Clifford ^b   Hatzaras, Ioannis ^c   Schmidt, Carl ^c   Winslow, Emily ^b   Staley Iii, Charles A ^a   Maithel, Shishir K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Intrahepatic cholangiocarcinoma; Lymphadenectomy; Lymphovascular invasion; Perineural invasion

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE LEAKAGE; CANCER INVASION; CANCER PROGNOSIS; CANCER SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH VESSEL; LYMPH VESSEL METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERINEURAL INVASION; PERINEURIUM; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; REOPERATION; TUMOR VOLUME;

EID: 84863718304     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00489.x     Document Type: Article

References (50)

1. Shaib Y, El-Serag HB,. (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24: 115-125.
2. Khan SA, Toledano MB, Taylor-Robinson SD,. (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB 10: 77-82.
3. Malhi H, Gores GJ,. (2006) Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45: 856-867.
4. Endo I, House MG, Klimstra DS, Gönen M, D'Angelica M, Dematteo RP, et al,. (2008) Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol 15: 2104-2112.
5. McGlynn KA, Tarone RE, El-Serag HB,. (2006) A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 15: 1198-1203.
6. Nakagawa T, Kamiyama T, Kurauchi N, Matsushita M, Nakanishi K, Kamachi H, et al,. (2005) Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 29: 728-733.
7. Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD,. (2007) Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg 11: 1488-1496; discussion 1496-1497.
8. Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, et al,. (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16: 3048-3056.
9. Todoroki T,. (2000) Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology 47: 644-649.
10. Alvaro D, Cannizzaro R, Labianca R, Valvo F, Farinati F,. (2010) Cholangiocarcinoma: a position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Dig Liver Dis 42: 831-838.
11. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al,. (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362: 1273-1281.
12. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA,. (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst Monogr 99: 433-441.
13. Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, et al,. (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15: 165-174.
14. Smith DD, Schwarz RR, Schwarz RE,. (2005) Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 23: 7114-7124.
15. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, et al,. (2011) Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 18: 651-658.
16. Ercolani G, Grazi GL, Ravaioli M, Grigioni WF, Cescon M, Gardini A, et al,. (2004) The role of lymphadenectomy for liver tumours: further considerations on the appropriateness of treatment strategy. Ann Surg 239: 202-209.
17. de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al,. (2011) Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 29: 3140-3145.
18. Clark CJ, Wood-Wentz CM, Reid-Lombardo KM, Kendrick ML, Huebner M, Que FG,. (2011) Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. HPB 13: 612-620.
19. Patel SH, Kooby DA, Staley CA, 3rd, Sarmiento JM, Maithel SK,. (2011) The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? HPB 13: 605-611.
20. Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, et al,. (2002) Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 49: 311-316.
21. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al,. (2009) Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 33: 1247-1254.
22. Gatto M, Bragazzi MC, Semeraro R, Napoli C, Gentile R, Torrice A, et al,. (2010) Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 42: 253-260.
23. Jarnagin WR, Shoup M,. (2004) Surgical management of cholangiocarcinoma. Semin Liver Dis 24: 189-199.
24. Aljiffry M, Walsh MJ, Molinari M,. (2009) Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 15: 4240-4262.
25. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, et al,. (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245: 755-762.
26. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, et al,. (2009) Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg 13: 1470-1479.
27. Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T, et al,. (2009) Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145: 411-416.
28. Yamamoto M, Takasaki K, Yoshikawa T,. (1999) Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol 29: 147-150.
29. Nathan H, Pawlik TM,. (2010) Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 26: 269-273.
30. Farges O, Fuks D, Le Treut YP, Azoulay D, Laurent A, Bachellier P, et al,. (2010) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer 117: 2170-2177.
31. Ito K, Ito H, Allen PJ, Gonen M, Klimstra D, D'Angelica MI, et al,. (2010) Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg 251: 675-681.
32. Cornwell LB, McMasters KM, Chagpar AB,. (2011) The impact of lymphovascular invasion on lymph node status in patients with breast cancer. Am Surg 77: 874-877.
33. Song YJ, Shin SH, Cho JS, Park MH, Yoon JH, Jegal YJ,. (2011) The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer. J Breast Cancer 14: 198-203.
34. Guntupalli SR, Zighelboim I, Kizer NT, Zhang Q, Powell MA, Thaker PH, et al,. (2012) Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Gynecol Oncol 124: 31-35.
35. Narayan K, Khaw P, Bernshaw D, Mileshkin L, Kondalsamy-Chennakesavan S,. (2012) Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy. Int J Gynecol Cancer 22: 260-266.
36. Royston D, Jackson DG,. (2009) Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 217: 608-619.
37. Gondo T, Nakashima J, Ozu C, Ohno Y, Horiguchi Y, Namiki K, et al,. (2011) Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy. Int J Clin Oncol. Epub 2011 Sept 7.
38. Brunocilla E, Pernetti R, Martorana G,. (2011) The prognostic role of lymphovascular invasion in urothelial-cell carcinoma of upper and lower urinary tract. Anticancer Res 31: 3503-3506.
39. de Mascarel I, Bonichon F, Durand M, Mauriac L, MacGrogan G, Soubeyran I, et al,. (1998) Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. Eur J Cancer 34: 58-65.
40. Shirabe K, Shimada M, Tsujita E, Aishima S, Maehara S, Tanaka S, et al,. (2004) Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis. Am J Surg 187: 538-542.
41. Chatterjee D, Katz MH, Rashid A, Aishima S, Maehara S, Tanaka S, et al,. (2012) Perineural and intraneural invasion in post-therapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Diagn Mol Pathol 36: 409-417.
42. Katz B, Srougi M, Dall'oglio M, Nesrallah AJ, Sant'anna AC, Pontes J, et al,. (2011) Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy. Urol Oncol. Epub 2011 July 25.
43. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D,. (2009) Perineural invasion in cancer: a review of the literature. Cancer 115: 3379-3391.
44. Peng J, Sheng W, Huang D, Venook AP, Xu Y, Guan Z, et al,. (2011) Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect. Cancer 117: 1415-1421.
45. Solares CA, Lee K, Parmar P, O'Rourke P, Panizza B,. (2012) Epidemiology of clinical perineural invasion in cutaneous squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 146: 746-751.
46. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al,. (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248: 84-96.
47. Chen TC, Jan YY, Yeh TS,. (2012) K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol. Epub 2012 Jan 31.
48. Scartozzi M, Galizia E, Verdecchia L, Berardi R, Graziano F, Catalano V, et al,. (2006) Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients. Br J Cancer 95: 445-449.
49. Du C, Zhou Y, Cai H, Zhao G, Fu H, Shi YQ,. (2012) Poor prognostic factors in patients with stage I gastric cancer according to the seventh edition TNM classification: a comparative analysis of three subgroups. J Surg Oncol 105: 323-328.
50. Bilici A, Seker M, Ustaalioglu BB, Kefeli U, Yildirim E, Yavuzer D, et al,. (2010) Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection. Ann Surg Oncol 17: 2037-2044.